← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2015Last known activity
Dec 31, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT04188301CollaboratorPhase 2Dec 31, 2019
- NCT04188301Overall official - principal investigatorPhase 2Dec 31, 2019
- NCT03517462CollaboratorN/AMay 31, 2018
- NCT02344628CollaboratorPhase 3Jun 1, 2015
Details
- Last known activity
- Dec 31, 2019